BRISTOL MYERS SQUIBB CO (BMY)

Healthcare · Pharmaceutical Preparations

BRISTOL MYERS SQUIBB CO (BMY) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.

Top institutional holders (2026-Q3)

InstitutionSharesValue% Outstanding
PZENA INVESTMENT MANAGEMENT LLC 14,244,839 $888.88M —
Robeco Institutional Asset Management B.V. 7,200,298 $449.30M —
DekaBank Deutsche Girozentrale 5,862,955 $368.7K —
Sumitomo Mitsui Trust Group, Inc. 5,072,993 $316.55M —
KBC Group NV 4,227,911 $263.8K —
Artemis Investment Management LLP 2,823,235 76.17M —
Mirae Asset Global Investments Co., Ltd. 2,769,316 — —
Swedbank AB 2,472,114 54.26M —

Recent insider transactions

DateInsiderTitleTypeValue
2026-09-09 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Sale $403.5K
2026-08-25 Holzer Phil M SVP and Controller Sale $33.8K
2026-04-01 Elkins David V EVP, Chief Financial Officer Sale .57M
2026-04-01 Elkins David V EVP, Chief Financial Officer Sale $278.0K

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.